Skip to content

Agreement of Two OCT Biometers: A Pilot Study

Agreement of Two OCT Biometers: A Pilot Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07782619
Enrollment
50
Registered
2026-08-24
Start date
2026-08-17
Completion date
2027-01-01
Last updated
2026-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Segment of Eye, Axial Length, Biometrics Measurement

Keywords

Biometer

Brief summary

The purpose of this study is to compare the measurements obtained with two different biometers, UNITY Dx and Anterion. In eye care, a biometer is a device that uses laser technology to take highly precise measurements of the eye's internal structures. It is most frequently used to help determine the exact power of the intraocular lens (IOL) needed before cataract removal.

Detailed description

The study population will consist of male and female adult subjects with a normal cornea (up to 10 subjects), keratoconus (up to 10 subjects), prior corneal laser vision correction (up to 10 subjects), current and habitual contact lens wear (up to 10 subjects), or dry eye (up to 10 subjects). In this single visit study, subjects will have data collected on one eye (unilateral) only. If both eyes meet the entry criteria, the right eye will be designated as the study eye.

Interventions

DEVICEUNITY DX

Investigational non-contact, non-invasive ophthalmic imaging and analysis device used for visualization of ocular structures and their optical properties

DEVICEANTERION

Commercially available non-contact, non-invasive ophthalmic imaging and analysis device used for visualization of ocular structures and their optical properties

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum

Inclusion criteria

* Have healthy, clear corneas for the normal cohort; * Have documented keratoconus for the keratoconus cohort; * Have reported use of daily contact lens use for the contact lens cohort; * Have documented dry eye, consisting of signs and symptoms for the dry eye cohort; * Has had previous keratorefractive surgery for the post-refractive surgery cohort; * Able to comprehend and sign the informed consent form.

Exclusion criteria

* Active ocular infection or inflammation; * Unable to fixate due to nystagmus or other eye movement abnormality (e.g., significant strabismus); * Any ocular disease and/or condition that, in the investigator's clinical judgment, may put the subject at significant risk, may compromise study result or may interfere significantly with the subject's participation in the study.

Design outcomes

Primary

MeasureTime frameDescription
Regression-Based Axial Length (R-AL)Day 1Regression-based Axial Length (R-AL) is the distance from the anterior surface of the cornea to the retina at the back of the eye, measured along the visual axis. R-AL will be measured by the device and reported in microns.

Countries

United States

Contacts

CONTACTAlcon Call Center
alcon.medinfo@alcon.com1-888-451-3937
STUDY_DIRECTORClinical Trial Lead, Surgical

Alcon Research, LLC

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 3, 2026